Vertex Pharmaceuticals (VRTX) closed at $453.74 in the latest trading session, marking a -1.31% move from the prior day. This ...

Think of training, communication and community as the three vertices of a triangle. Lose any one, and the structure collapses ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...

UTime (WTO) announced its Hong Kong subsidiary, UTime Technology, has officially signed a smart health device procurement ...

Amazon ( AMZN +0.26%) continues to underscore the strength of its business and deliver fantastic growth for long-term ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

AI agents are moving rapidly from experimentation to everyday business use, but choosing the right platform can feel ...

The new cyberspace chain-reaction bullet hell shooter Hyper Detonator has been announced for Steam, aiming for a Q2 2026 ...

Equity Insider News Commentary - The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The ...

UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices today announced a major commercial breakthrough. UTime’s Hong Kong subsidiary, UTime ...

Alphabet is the most complete end-to-end AI company on the planet, and the advantages of its vertical integration and its ...

Medical breakthroughs 2025 report highlights FDA approvals, gene therapies, and robotic telesurgery advancing patient care this year.